Abingdon, United Kingdom

Thomas Stephen Coutler


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Stephen Coutler: Innovator in Immunomodulatory Compounds

Introduction

Thomas Stephen Coutler is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of immunology through his innovative research and development of novel compounds. His work focuses on addressing various medical conditions that may benefit from immunomodulation.

Latest Patents

Coutler holds a patent for immunomodulatory compounds. This invention relates to novel heterocyclic compounds, methods for their preparation, and compositions containing them. The patent also outlines methods and uses for clinical treatment of medical conditions such as rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosus, and psoriasis. More specifically, the invention involves CD80 antagonists capable of inhibiting the interactions between CD80 and CD28.

Career Highlights

Coutler is currently associated with Active Biotech AB, where he continues to advance his research in immunomodulatory therapies. His work has the potential to impact the treatment landscape for several chronic diseases.

Collaborations

Coutler has collaborated with notable colleagues, including Ian Richard Matthews and Chiara Ghiron. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of immunology.

Conclusion

Thomas Stephen Coutler is a distinguished inventor whose work in immunomodulatory compounds holds promise for improving treatments for various medical conditions. His contributions to the field are noteworthy and continue to influence ongoing research and development efforts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…